ESF to review synchrotron needs of biological and biomedical research

The European Science Foundation is to carry out a Europe-wide assessment of the future scientific needs for synchrotrons for biological and biomedical research, following a request from the UK’s Medical Research Council.

At its meeting on 27th November 1997, the ESF Executive Council approved the setting up of this latest ESF European review at a time when there are growing indications that demand for access to synchrotrons from European biologists is increasing markedly.

The review will concentrate on current and future beamline provision, current and projected demand for access, how that demand is being and should be met, and the impact of future technical developments. It is intended that the review will provide an authoritative ‘platform’ of scientifically-orientated advice as a basis for policy decision making. It will be carried out in the first part of 1998 and will be independent of both the users and the providers of synchrotron facilities, whilst drawing evidence from both of them.

The terms of reference and membership of the review panel will be finalised in the coming weeks in consultation with the relevant ESF Standing Committees for approval by the ESF Board in January 1998. A final report is expected to be published no later than the autumn of 1998.

Ends

Notes for editors:

1. The European Science Foundation is an association of 62 major national funding agencies devoted to scientific research in 21 countries. The ESF assists its member organisations in two main ways: by bringing scientists together in its scientific programmes, networks and European research conferences, to work on topics of common concern, and through the joint study of issues of strategic importance in European science policy.

For further information contact: Andrew Smith

Category: Media Centre, Press Releases 1997